BACKGROUND:The objective of the current study was to evaluate the prognostic significance of the maximum standardized uptake value (SUV max ) of F-18 fluorodeoxyglucose (FDG) as measured by positron emission tomography (PET) in pelvic lymph nodes in patients with cervical cancer. METHODS: The authors studied cervical cancer patients with pelvic lymph node metastasis, as evidenced on FDG-PET, who were treated between November 2003 and October 2008. The maximum dimension and SUV max for the most FDG-avid pelvic lymph node (SUV PLN ) and the SUV max of the primary cervical tumor (SUV cervix ) were recorded from the FDG-PET/computed tomography (CT) scan. The SUV PLN was analyzed for its association with treatment response, pelvic disease recurrence, disease-specific survival, and overall survival. RESULTS: The population was comprised of 83 women with International Federation of Gynecology and Obstetrics (FIGO) stages IB1 to IIIB cervical cancer. The average SUV PLN was 6.9 (range, 2.1-33.0), whereas the average SUV cervix was 14.0 (range, 3.2-38.4). The SUV cervix and SUV PLN were found to be weakly correlated (correlation coefficient [R 2 ] ¼ 0.301). The average size of the pelvic lymph nodes was 2.1 cm (range, 0.6-7.9